Helius Medical Technologies (NASDAQ:HSDT – Get Free Report) issued its quarterly earnings data on Monday. The company reported ($0.64) EPS for the quarter, missing analysts’ consensus estimates of ($0.50) by ($0.14), Zacks reports. The business had revenue of $0.18 million during the quarter. Helius Medical Technologies had a negative net margin of 1,328.14% and a negative return on equity of 297.49%. During the same quarter last year, the firm posted ($3.00) earnings per share.
Helius Medical Technologies Stock Performance
NASDAQ HSDT traded down $0.07 during trading hours on Wednesday, reaching $0.68. The company’s stock had a trading volume of 35,811 shares, compared to its average volume of 326,800. Helius Medical Technologies has a fifty-two week low of $0.65 and a fifty-two week high of $13.43. The stock has a market cap of $2.02 million, a PE ratio of -0.06 and a beta of 1.60. The company’s 50-day moving average is $0.91 and its two-hundred day moving average is $3.33.
Helius Medical Technologies Company Profile
Recommended Stories
- Five stocks we like better than Helius Medical Technologies
- Options Trading – Understanding Strike Price
- Brinker International’s Price Dip is an Appetizing Entry Point
- There Are Different Types of Stock To Invest In
- 3 Stocks That Could Beat the September Blues
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Canopy Growth Stock: Can It Sustain Recent Gains?
Receive News & Ratings for Helius Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Helius Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.